Mitogen-activated protein kinase phosphatase-1 expression in macrophages is controlled by lymphocytes during macrophage activation

International Journal of Molecular Medicine

Volumn 29, Issue 1, 2012, Pages 25-31

  Luo, Chong ^a   Yang, Xiqiang ^a   Yao, Lan ^a   Jiang, Liping ^a   Liu, Wei ^a   Li, Xin ^a   Wang, Lijia ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Endotoxemia; Lymphocyte deficiency; Macrophages; Mitogen activated protein kinase phosphatase 1

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; ASCITIC FLUID; DUAL SPECIFICITY PHOSPHATASE 1; ENDOTOXEMIA; FEMALE; INFLAMMATION; INTERLEUKIN-10; KAPLAN-MEIER ESTIMATE; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, SCID; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855176092     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.799     Document Type: Article

References (33)

1. Vincent JL, Martinez EO and Silva E: Evolving concepts in sepsis definitions. Crit Care Nurs Clin North Am 23: 29-39, 2011.
2. Filipovich AH: Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009: 127-131, 2009.
3. Wong SS and Yuen KY: The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother 62: 437-441, 2008.
4. To KK, Hung IF, Li IW, et al.: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859, 2010.
5. Goncalves GM, Zamboni DS and Camara NO: The role of innate immunity in sepsitc acute kidney injuries. Shock (Suppl 1): 22-26, 2010.
6. Iwakiri D, Zhou L, Samanta M, et al.: Epstein-Barr virus (EBV)- encoded small RNA is related from EBV-infected cells and activates signaling from Toll-like receptors. J Exp Med 206: 2091-2099, 2009.
7. Frieman M, Heise M and Baric R: SARS coronavirus and innate immunity. Virus Res 133: 101-112, 2008. (Pubitemid 351374752)
8. Zhou J, Yang XQ, Fu Z, Zhao XD, Jiang LP, Wang LJ and Cui YX: Increase pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice. Med Microbiol Immunol 197: 345-351, 2008.
9. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H and Fu YX: Adaptive immune cells temper initial innate responses. Nat Med 13: 1248-1252, 2007. (Pubitemid 47530627)
10. Keyse SM: Protein phosphatases and the regulation of mitogen-activated protein kinase signaling. Curr Opin Cell Biol 12: 146-150, 2000.
11. Li L, Chen SF and Liu Y: MAP kinase phosphatase-1, a critical negative regulator of the innate immune response. Int J Clin Exp Med 2: 48-67, 2009.
12. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC and Lang R: Dual specificity phosphatase1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203: 15-20, 2006. (Pubitemid 43139639)
13. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA and Oravecz T: Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol 176: 1899-1907, 2006. (Pubitemid 43134335)
14. van Schaik SM and Abbas AK: Role of T cells in a murine model of Escherichia coli sepsis. Eur J Immunol 37: 3101-3110, 2007. (Pubitemid 350131289)
15. +T-cell depletion is not associated with alterations in survival, bacterial clearance, and inflammation after cecal ligation and puncture. Shock 29: 56-64, 2008.
16. Kolaczkowska E, Barteczko M, Plytycz B and Arnold B: Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflamm Res 57: 272-278, 2009.
17. Reim D, Westenfelder K, Kaiser-Moore S, Schlautkotter S, Holzmann B and Weighardt H: Role of T cells for cytokine production and outcome in a model of acute septic peritonitis. Shock 31: 245-250, 2009.
18. Martignoni A, Tschöp J, Goetzman HS, Choi LG, Reid MD, Johannigman JA, Lentsch AB and Caldwell CC: CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock 29: 591-597, 2008. (Pubitemid 351544079)
19. Remick DG, Newcomb DE, Bolgos GL and Call DR: Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13: 110-116, 2000.
20. Davies B and Cohen J: Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect Dis 11: 65-71, 2011.
21. Luo C, Yang XQ, Li X, Liu W and Wang LJ: Comparation of inflammation between wild and severe combined immuno deficiency mice with endotoxemia induced by lipopolysaccharide. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27: 44-46, 2011 (In Chinese).
22. Khan S, Shin EM, Choi RJ, Jung YH, Kim J, Tosun A and Kim YS: Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages. J Cell Biochem 112: 2179-2188, 2011.
23. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P and Wouters C: Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6 and TNF-alpha-producing macrophages. Blood 105: 1648-1651, 2005. (Pubitemid 40223686)
24. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A and Grom AA: Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7: R30-R37, 2005.
25. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, Bennett AM and Flavell RA: Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 103: 2274-2279, 2006. (Pubitemid 43271660)
26. Jacob A, Rajan D, Pathickal B, Balouch I, Hartman A, Wu R, Zhou M and Wang P: The inhibitory effect of ghrelin on sepsis-induced inflammation is mediated by the MAPK phosphatase-1. Int J Mol Med 25: 159-164, 2010.
27. Franklin CC and Kraft AS: Conditional expression of the mitogen-activated protein kinase (MAPK) phophatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272: 16917-16923, 1997. (Pubitemid 27289792)
28. Zhao Q, Wang X, Nelin LD, et al.: MAP kinase phosphatase 1 controls innate immune response and suppresses endotoxic shock. J Exp Med 203: 131-140, 2006. (Pubitemid 43139652)
29. Wang X and Liu Y: Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal 19: 1372-1382, 2007. (Pubitemid 46830880)
30. Shipp LE, Lee JV, Yu CY, Pufall M, Zhang P, Scott DK and Wang JC: Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PLoS One 5: e13754, 2010.
31. Sohaskey ML and Ferrell JE Jr: Activation of p42 mitogen-activated protein kinase(MAPK), but not c-Jun NH(2)-terminal kinase, induces phosphorylation and stabilization of MAPK phosphatase XCL 100 in Xenopus oocytes. Mol Biol Cell 13: 454-468, 2002. (Pubitemid 34165075)
32. Cao W, Bao C, Padalko E and Lowenstein CJ: Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling. J Exp Med 205: 1491-1503, 2008. (Pubitemid 351831502)
33. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC and Liu Y: Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide stimulated macrophages. J Immunol 169: 6408-6416, 2002. (Pubitemid 36903490)